This topic contains a solution. Click here to go to the answer

Author Question: What condition would the EMT associate with a hypoxic respiratory drive? A) Congestive heart ... (Read 10 times)

Shelles

  • Hero Member
  • *****
  • Posts: 582
What condition would the EMT associate with a hypoxic respiratory drive?
 
  A) Congestive heart failure
  B) Pneumonia
  C) Chronic obstructive pulmonary disease
  D) Diabetes

Question 2

To assess the O of the OPQRST mnemonic in a patient who is having chest pain, you should ask:
 
  A) Are you having any other signs or symptoms?
  B) What were you doing when the pain began?
  C) How many times has this happened in the past?
  D) On a scale of 1 to 10, with 10 being the worst, how would you rate your pain?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

b614102004

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

C

Answer to Question 2

B




Shelles

  • Member
  • Posts: 582
Reply 2 on: Jul 3, 2018
Excellent


Joy Chen

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

According to research, pregnant women tend to eat more if carrying a baby boy. Male fetuses may secrete a chemical that stimulates their mothers to step up her energy intake.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library